Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Idiopathic Autism Spectrum Disorder and Fragile X Syndrome: A Pilot Study.
Adolescent
Adult
Animals
Autism Spectrum Disorder
/ diagnostic imaging
Brain
/ diagnostic imaging
Cerebral Cortex
/ diagnostic imaging
Female
Fragile X Syndrome
/ diagnostic imaging
Humans
Male
Middle Aged
Pilot Projects
Positron-Emission Tomography
/ methods
Receptor, Metabotropic Glutamate 5
/ genetics
Young Adult
binding potential
caudate nucleus
cingulate
cortex
fragile X mental retardation 1 gene (FMR1)
neurodevelopmental disorders
positron emission tomography (PET)
putamen
radiotracer
thalamus
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Mar 2021
11 Mar 2021
Historique:
received:
31
01
2021
revised:
26
02
2021
accepted:
04
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
5
2021
Statut:
epublish
Résumé
Multiple lines of evidence suggest that dysfunction of the metabotropic glutamate receptor subtype 5 (mGluR
Identifiants
pubmed: 33799851
pii: ijms22062863
doi: 10.3390/ijms22062863
pmc: PMC7999711
pii:
doi:
Substances chimiques
Receptor, Metabotropic Glutamate 5
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NICHD NIH HHS
ID : P50 HD103538
Pays : United States
Organisme : Radiology BRidge/Development Funding Initiative to STimulate and Advance Research (RAD BriteStar Bridge) Award from the Johns Hopkins University School of Medicine, Baltimore, Maryland
ID : 80046104
Organisme : NCATS NIH HHS
ID : UL1 TR003098
Pays : United States
Organisme : NIH HHS
ID : U54 HD07912
Pays : United States
Références
J Cereb Blood Flow Metab. 2011 Feb;31(2):535-46
pubmed: 20808318
J Biol Chem. 2017 Dec 15;292(50):20592-20598
pubmed: 28974579
J Nucl Med. 1997 Oct;38(10):1614-23
pubmed: 9379202
Pediatr Neurol. 2019 Nov;100:12-25
pubmed: 31416725
Brain Behav Immun. 2015 Oct;49:197-205
pubmed: 26052099
Exp Neurol. 2018 Sep;307:74-81
pubmed: 29782864
Synapse. 2012 Jun;66(6):471-82
pubmed: 22223404
J Child Psychol Psychiatry. 2021 Jan 11;:
pubmed: 33432656
J Cereb Blood Flow Metab. 2013 Apr;33(4):532-41
pubmed: 23250105
J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
pubmed: 17519979
Magn Reson Imaging Clin N Am. 2017 May;25(2):231-243
pubmed: 28390525
J Neurodev Disord. 2020 May 2;12(1):13
pubmed: 32359368
Neurosci Biobehav Rev. 2015 May;52:172-7
pubmed: 25704074
Schizophr Res. 2015 Sep;167(1-3):42-56
pubmed: 25432637
Neurochem Int. 2020 Dec;141:104853
pubmed: 32980494
Brain Res Bull. 2011 Oct 10;86(3-4):152-8
pubmed: 21840381
Curr Opin Genet Dev. 2020 Dec;65:126-137
pubmed: 32659636
Phys Med Biol. 2007 Mar 7;52(5):1505-26
pubmed: 17301468
Brain Sci. 2020 Nov 24;10(12):
pubmed: 33255214
Annu Rev Neurosci. 2020 Jul 8;43:509-533
pubmed: 32640929
Transl Neurosci. 2017 Mar 11;8:7-8
pubmed: 28400977
Int J Mol Sci. 2020 Dec 23;22(1):
pubmed: 33374598
Neurosci Biobehav Rev. 2020 Dec;119:217-241
pubmed: 33039453
J Nucl Med. 2013 Mar;54(3):388-96
pubmed: 23404089
Int J Mol Sci. 2019 Mar 20;20(6):
pubmed: 30897826
MethodsX. 2019 Jan 04;6:169-189
pubmed: 30733930
Cell Signal. 2020 Nov;75:109746
pubmed: 32858122
Int J Mol Sci. 2020 Jul 02;21(13):
pubmed: 32630718
Am J Med Genet A. 2006 Sep 1;140A(17):1814-26
pubmed: 16906564
J Autism Dev Disord. 1989 Jun;19(2):185-212
pubmed: 2745388
Trends Neurosci. 2004 Jul;27(7):370-7
pubmed: 15219735
Brain Sci. 2020 Sep 30;10(10):
pubmed: 33008014
Dev Neurosci. 2011;33(5):379-94
pubmed: 21893949
Science. 1984 Dec 21;226(4681):1393-6
pubmed: 6334363
J Neurodev Disord. 2017 Jun 12;9:14
pubmed: 28616097
Cerebellum Ataxias. 2018 Feb 12;5:3
pubmed: 29449954
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Mol Cell Proteomics. 2020 Dec;19(12):1952-1968
pubmed: 32912969